Active Implants Receives FDA Breakthrough Device Designation for NUsurface® Meniscus Implant

Active Implants Receives FDA Breakthrough Device Designation for NUsurface® Meniscus Implant Designation Allows Expedited Review of First “Artificial Meniscus”   MEMPHIS, Tenn. – September 19, 2019 – Active Implants, LLC, a developer of orthopedic implant solutions for joint preservation, today announced that the NUsurface® Meniscus Implant has been granted a Breakthrough Device Designation from the…